Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Omodei

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Ecancermedicalscience|January 26, 2012
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trialM Lazzeroni, D Macis, A Decensi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2013
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT studyA DeCensi, B Bonanni, P Maisonneuve, et al.
Climacteric : the Journal of the International Menopause Society|January 7, 2006
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional studyP Di Donato, N A Giulini, A Bacchi Modena, et al.
Maturitas|November 1, 2005
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in ItalyP Di Donato, N A Giulini, A Bacchi Modena, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Ecancermedicalscience|January 26, 2012
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trialM Lazzeroni, D Macis, A Decensi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2013
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT studyA DeCensi, B Bonanni, P Maisonneuve, et al.
Climacteric : the Journal of the International Menopause Society|January 7, 2006
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional studyP Di Donato, N A Giulini, A Bacchi Modena, et al.
Maturitas|November 1, 2005
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in ItalyP Di Donato, N A Giulini, A Bacchi Modena, et al.
Pageof 2